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Abstract- The use of lithium in medicine began in the mid-19th century, when the solubility of uric acid salts 
in the solution of lithium carbonate was demonstrated in vitro, which meant that lithium could be used in the 
treatment of gout. The use of lithium in psychiatry starts in 1949, when the effect of lithium in the treatment 
of mania was demonstrated. The mechanism of action of lithium is not yet completely understood. In parallel 
with the use of lithium in the treatment of psychiatric disorders, different methods for the determination of 
lithium in human samples have been developed. The first aim of the study was to determine the amount of 
lithium in serum samples using electrochemical methods, flame photometry and spectrophotometry and use 
the results to compare the results obtained using these methods. Because of the possibility of determining 
lithium in various media, the second aim of the study was to evaluate the clinical value of determining the 
concentration of lithium in erythrocytes in relation to the concentration of lithium in plasma. The third aim 
was to investigate the extent to which a therapeutic dose of lithium correlates with the measured concentra-
tions of lithium in serum, plasma and erythrocytes. It was concluded that statistically there was no significant 
difference between the three test laboratory methods (P = 0.507). Investigating the correlation between the 
concentration of lithium in various media measured by different methods and the daily therapeutic dose 
of lithium, it was concluded that  statistically a significant correlation was found only in serum lithium con-
centrations measured with electrochemical method (P = 0.009; r = 0.47). There was statistically a significant 
moderate correlation between the concentration of lithium in plasma and erythrocytes (P = 0.002; r = - 0.54), 
and the lithium concentration erythrocytes are higher than lithium concentrations in plasma (P = 0,043). The 
range of the ratio of the concentration of lithium in erythrocytes and plasma is wide (13.25 to 111.15), and 
is not in correlation with the therapeutic daily dose and therefore is not a better indicator in the control of 
the treatment.
Keywords: lithium ion-selective electrodes, flame photometry, spectrophotometry
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Introduction
The use of  lithium in medicine began in 
the mid-19th century. Lithium was first used 
to treat gout.
The use of  lithium in psychiatry starts in 
1949, in the treatment of  acute depression 
and acute mania. The US Food and Drug 
Administration (FDA) approved the use of  
lithium to treat mania in 1970 [8,18]. Today, 
lithium is used in the treatment of  bipolar 
disorder, depressive disorder and schizo-
phrenia [22]. Lithium is absorbed from the 
gastrointestinal tract within six to eight hours. 
Peak plasma concentrations are achieved 
1-2 hours or 5-6 hours after administration, 
depending on whether it is a fast or slow 
release form, but peak concentrations in the 
brain are achieved 2 hours after the peak of  
plasma concentrations. Lithium is excreted 
in the urine. Elimination half-life is 20 hours 
[11]. The exact mechanism of  action of  lith-
ium as a mood stabilizer is still unknown, 
despite numerous studies that have been 
conducted. Lithium has short and long term 
effects on cells of  the central nervous sys-
tem, the signaling pathway and there is also 
a lot of  evidence that lithium changes neu-
ral plasticity by acting on apoptotic mecha-
nisms [19]. Lithium has an effect on the fol-
lowing enzymes: inositol monophosphate, 
inositol-1-plilfostfat phosphatase; glycogen 
synthase kinase-3; bisphosphate nucleotid-
ase, fructose-1,6.bifosfatase and phospho-
glucomutase [22]. Because lithium is toxic, 
and also has a narrow therapeutic range, it is 
very important to monitor lithium concen-
trations in body fluids, plasma and serum or 
in cells. The therapeutic range for lithium in 
serums is from 0.6 mmol / L to 1.2 mmol / 
L. Measurement of  lithium levels in serum 
is carried out 12 hours after the last dose. 
The toxic concentration of  lithium in se-
rum is above 1.5 mmol / L. The methods 
used today to determine lithium concentra-
tion are spectrophotometry, electrochemi-
cal methods (ion-selective electrodes - ISE) 
and atomic absorption spectrometry (AAS). 
The aim of  this study was to measure the 
concentration of  lithium by different meth-
ods and in different human samples: serum, 
plasma and erythrocytes and to determine 
which one is the most reliable for assessing 
therapeutic width as a function of  the ap-
plied dose of  lithium.
Subjects and Methods
Subjects
The study included 41 psychiatric patients, 
with diagnosed bipolar disorder, schizoaffec-
tive disorder, schizophrenia and depression. 
The psychiatric diagnose was determined by 
using DSM 5 as criterion. The group consist-
ed of  12 women and 29 men with ages  rang-
ing from 32 to 76. The criterion for inclu-
sion was the presence of  lithium therapy for 
a specific psychiatric disorder. The study in-
volved patients who, due to lithium treatment 
should control the concentration of  lithium 
in blood and for the purposes of  this study 
we used their residual venous blood samples. 
All venous blood sampling was conducted 
12 hours after the last dose of  lithium, as 
the physician prescribed the routine medical 
procedures. This test did not have any effect 
on the laboratory or therapeutic method for 
patients. Two tubes of  3 ml volume venous 
blood were taken from each patient. One 
tube of  blood that was drawn into the tubes 
without anticoagulant was used for the re-
covery of  serum, while other tube of  venous 
blood was taken in a test tube containing an 
anticoagulant K3EDTA (ethylenediamine-
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tetraacetic acid) and was used to obtain the 
plasma and hemolysate. 
Laboratory procedures
In venous blood samples hematocrit lev-
els (HTC) were determined by the hematolo-
gy analyzers DxH, Beckman Coulter (Miami, 
USA) and Sysmex XE1000i (Kobe, Japan). 
Venous blood samples, used for serum prep-
aration, were stored at room temperature for 
30 min, as it is required to complete the pro-
cess of  spontaneous blood clotting, and then 
were centrifuged for 10 min, with the power 
of  the centrifuge of  3500 rotations / minute 
(r/min) at room temperature. From the ve-
nous blood samplesthat were used to acquire 
plasma, we first isolated 0.5 ml of  blood to 
acquire hemolysate. The 0.5 ml   ofisolated 
blood for hemolysate preparation was mixed 
with 2 ml of  double-distilled water and there-
by obtained a sample of  hemolysate in which 
we determined the concentration of  lithium. 
The remaining blood samples were imme-
diately centrifuged for 10 min with the cen-
trifugal force of  3500 r / min, at room tem-
perature. After centrifugation, the separated 
plasma sample of  0.5 mL was mixed with 2 
ml of  double-distilled water. In these diluted 
plasma samples we determined the concen-
tration of  lithium. Lithium concentrations in 
serum samples were determined using spec-
trophotometry on the machine VITROS 250, 
(Johnson & Johnson, New Jersey). The exact 
principle of  the method is achieved by us-
ing a multi-layer film (Vitros Li Slide). On the 
top of  the film the machine pipetted 10μL 
sample in which it is necessary to determine 
the amount of  lithium. The sample passes 
to the lower film layer where lithium in the 
sample specifically binds to the azo dye with 
which it forms a colored complex and the in-
tensity of  color complex formed is measured 
at a wavelength of  600 nm with spectropho-
tometric method. Lithium concentrations in 
serum samples were determined on the ma-
chine Rosche Cobas Integra 400 (Rotkreuz, 
Switzerland). This electrochemical method 
using ion-selective electrodes can not be used 
to determine the concentration of  lithium in 
the hemolysate due to interference of  hemo-
globin, neitherfor determining lithium con-
centrations in plasma due to the interference 
of  EDTA. All hemoglobin levels higher than 
0.06 mmol / L in a sample significantly inter-
fere with the determination of  the concen-
tration of  lithium. The exact mechanism of  
interference of  hemoglobin and EDTA with 
ion-selective electrode apparatus Rosche Co-
bas Integra 400 is not available, because the 
part of  the membrane which provides selec-
tivity for lithium is still protected by a patent. 
Lithium concentrations in serum, plasma and 
hemolysate, by flame photometry, were de-
termined on the machine IL943.
Statistical methods
To show the results and statistical data we 
used computer programs Excel 2010, Micro-
soft Office (Microsoft USA) and statistical 
program MedCalc in. 13.3. (MedCalc Soft-
ware, Mariakerke, Belgium). We presented the 
characteristics of  the test group of  patients 
and the ratio of  concentrations in erythro-
cytes and plasma obtained by flame photom-
etry using descriptive analysis. Datasets were 
tested with the Kolmogorov-Smirnov statis-
tical test for normality of  distribution. Cor-
relation coefficients were interpreted accord-
ing to Colton. We used the model of  linear 
regression to estimate the dependent variable 
in relation to the prediction factor on a level 
of  statistical significance of  P <0.05.
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Results
The group of  41 patients, aging from 32 
to 76 years, did not have a balanced propor-
tion of  men (N = 29) and women (N = 12), 
as shown in Figure 1. The subjects had been 
diagnosed with different mental disorders. 
30 patients were diagnosed with bipolar dis-
orders, 3 patients had been diagnosed with 
schizophrenia, 3 patients were treated for 
schizoaffective disorder, one patient was di-
agnosed with depression, and 4 patients had 
no diagnosis recorded. The group of  patients 
also differed in the daily dose of  lithium pre-
scribed. The total daily intake of  lithium for 
30 patients was in the range from 600 mg to 
1800 mg of  lithium daily.
Comparison of methods
The first aim of  this study was to compare 
the concentration of  lithium in the serum 
obtained using three different methods: using 
spectrophotometry, electrochemical methods 
Table 2. This table shows the age of  patients, the daily therapeutic dose of  lithium, lithium con-
centration in plasma and erythrocytes measured by flame photometry and the concentration of  
lithium in serum measured by flame photometry, electrochemical method and the method of  spec-
trophotometry.
N Median 95% CI Minimum Maximum 25 - 75 P P
Age 41 45 43-53 32 76 39-58 0.2370
Daily dose 
of  Li  (mg)
30 900.0 900.0-900.0 600.0 1800.0 750.0-900.0 0.0005
Concentration of  
Li in erythrocytes 
(mmol/L)
31 0.78 0.56-0.97 0.37 1.55 0.52-1.10 0.194
Concentration 
of  Li in plasma 
(mmol/L)
31 0.67 0.56-0.80 0.40 0.94 0.51-0.82 0.008
Concentration of  
Li in serum– PF 
(mmol/L)
31 0.71 0.62-0.83 0.29 1.02 0.56-0.89 0.424
Concentration of  
Li in serum– ISE 
(mmol/L)
41 0.60 0.50-0.70 0.23 1.00 0.44-0.77 0.113
Concentration of  Li 
in serum – Vitros 
(mmol/L)
23 0.49 0.43-0.62 0.18 0.97 0.38-0.63 0.444
N – number of  patients; CI – reliability interval of  95%;  25 – 75 P – the range of  variables from 
25th to 75th percentiles; P – level of  statistical significance ; PF – flame photometry, ISE – ion-selec-
tive elektrode; Vitros –  spectrophotometry.
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and flame photometry. The serum concen-
tration of  lithium using all three methods 
was determined on 13 samples and statisti-
cally analysed, using the ANOVA test. It was 
found that there was statistically no signifi-
cant difference between the three methods 
used (P = 0.507).
Determination of lithium in erythrocytes
The second aim of  this study was to com-
pare the calculated concentration of  lithium 
in erythrocytes to plasma concentration and 
make an assessment of  the clinical value of  
determining the concentration of  lithium in 
erythrocytes compared to plasma. The con-
centration of  lithium in erythrocytes is cal-
culated using the measured concentrations 
of  lithium in the hemolysate and plasma by 
flame photometry. The values of  lithium in 
erythrocytes are calculated using a mathemat-
ical model [17].
Figure 2. The comparison of  lithium levels in serum measured using three different methods; 
1-ion-selective electrode, 2 flame photometry, 3-spectrophotometry; P = 0.507.
Method
 (Li level in blood –Li level in plasma) (1 – Htc)
Conc. of  Li in Erc (mmol/L) = 
 Htc
The ratio of  lithium in erythrocytes and in plasma can be calculated using the concentra-
tion of  lithium in the erythrocytes [17].
 conc. of  Li in Erc (mmol/L) x 100
Conc.of  Li in Erc /conc.of  Li in plasma = 
 conc.of  Li in plazmi (mmol/L)
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Reviewing the ratio of  the concentra-
tion of  lithium in erythrocytes and plasma, 
which is quite a wide range of  values (13.25 
to 111.15), we can conclude that lithium con-
centrations in red blood cells do not fully re-
flect the concentration of  lithium in plasma.
There was statistically a significant, mod-
erate correlation between the concentration 
Table 3. Concentration of  Li in plasma and erythrocytes measured with flame photometry, hema-
tocrit, and the ratio of  the concentration of  lithium in erythrocytes and in plasma.
N Median 95% CI Minimum Maximum 25-75 P P
Concentration 
of  Li in plasma 
(mmol/L)
31 0.67 0.56-0.80 0.40 0.94 0.51-0.82 0.008
Concentration of  
Li in erythrocytes 
(mmol/L)
31 0.78 0.56-0.97 0.37 1.55 0.52-1.10 0.194
Hematocrit (L/L) 31 0.437 0.423-0.455 0.351 0.516 0.413-0.458 0.918
 Erc/P 31 31.00 23.30-40.16 13.25 111.15 20.50-47.85 0.001
N – number of  patients; CI – reliability interval of  95%;  25 – 75 P – the range of  variables from 
25th to 75th percentiles; P – level of  statistical significance.
Figure 3. Correlation of  lithium levels in plasma and in erythrocytes; P = 0.002; r = - 0.54. 
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of  lithium in plasma measured with the flame 
photometer and the calculated concentration 
of  lithium in erythrocytes (P = 0.002; r = - 
0.54).
Comparison of  the concentration of  lith-
ium in plasma and erythrocytes was evalu-
ated by using the parametric t-test because 
of  the normal distribution. Among them 
there is statistically a significant difference (P 
= 0.043), and we conclude that the value of  
lithium in erythrocytes is significantly higher 
than in plasma.
The correlation between a therapeutic dose 
of lithium to lithium concentrations in serum, 
plasma and erythrocytes
In this study we evaluated the correla-
tion of  lithium levels in serum, plasma and 
red blood cells and the therapeutic doses of  
lithium. As a limit for determining statistical 
significance, we used P<0.05.
Figure 4. Comparison of  the concentration of  potassium in the plasma and the red blood cells 
measured by flame photometry; P = 0.043.
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Figure 5. Correlation of  lithium concentrations in plasma measured by flame photometry and the 
therapeutic dose of  lithium; P = 0.932; r = - 0.02
Figure 6. Correlation of  serum lithium concentrations measured by flame photometry with the 
therapeutic dose of  lithium; P = 0.078; r = 0.34
107
Alcoholism and Psychiatry Research 2017;53:99-114Lithium Concentration in Serum, Plasma and Erythrocytes
Figure 8. Correlation of  the concentration of  lithium in serum measured by spectrophotometry 
method and the therapeutic dose of  lithium; P = 0.167; r = 0.41
Figure 7. Correlation of  serum lithium concentrations measured with the electrochemical method 
and the therapeutic dose of  lithium; P = 0.009; r = 0.47
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Figure 9. Correlation of   lithium concentrations in red blood cells and  the therapeutic dose of  
lithium; P = 0.526; r = - 0.12.
Table 4. Correlation of  therapeutic dose of  lithium to the concentration of  lithium in different 
samples measured using three different methods.
Sample method r P
serum PF 0.34 0.078
serum ISE 0.47 0.009
serum VITROS 0.41 0.167
plasma PF -0.02 0.932
erythrocytes PF -0.12 0.526
   (Erc/P) summary -0.10 0.61
PF - flame photometry; ISE - electrochemical method, ion selective electrode; VITROS - spectro-
photometry; r - correlation coefficient according to Colton; P - level of  statistical significance
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Concentrations of  lithium in plasma and 
in erythrocytes do not correlate with the 
therapeutic dose of  lithium or the ratio of  
the concentration of  lithium in plasma and 
erythrocytes. The serum concentrations are 
positive dose-related. The higher the doses 
the higher are the concentrations. But this 
correlation cannot be subordinated to lin-
ear regression (r = 0.34; r = 0.41 r = 0.47). 
The correlation coefficients are low (rating 
by Colton), and statistically significant only in 
the electrochemical methods (P = 0.009).
It can be concluded that the concentration 
of  lithium in serum determined by using the 
electrochemical method best correlates with 
a daily dose of  lithium.
Discussion
As the use of  lithium in medicine began 
it was important to develope methods for 
determining the concentration of  lithium 
in the blood of  patients for follow-up treat-
ment, in order to avoid side effects and tox-
icity and to reduce relapses. Lithium has a 
narrow therapeutic range and the reference 
range for lithium concentrations in serum 
and plasma, in patients who are treated with 
lithium compounds is between 0.6 mmol / L 
to 1.2 mmol / L. Concentrations above 1.5 
mmol / L are considered toxic. Therapeutic 
lithium overdose, due to its narrow therapeu-
tic range,  is more frequent than an overdose 
as a result of  deliberate or accidental intake 
of  large quantities of  the drug. The first signs 
of  poisoning are gastrointestinal symptoms 
(nausea, vomiting, diarrhea), muscle weak-
ness, impaired coordination, drowsiness or 
lethargy, even ataxia, dizziness, blurred vi-
sion, tinnitus, disorientation, muscle cramps, 
and larger amounts of  diluted urine. If  the 
concentration of  lithium in the blood in-
creases above 2-3 mmol / L patients may 
present with disorientation and convulsions, 
coma and death. In the 1970s the importance 
of  the determination of  the concentration of  
lithium in erythrocytes and the ratio of  the 
concentration of  lithium in erythrocytes and 
in plasma as a possible prognostic indicators 
was realized, due to the assumption that the 
concentration of  lithium in erythrocytes bet-
ter reflects the concentration of  lithium in 
the brain and the neurons. 
 There was an assumption that there might 
be four ways of  lithium entry into erythro-
cytes: passive diffusion, diffusion with bi-
carbonate ions, lithium replacing sodium in 
the system Na + / K + -ATPase (adenosine 
triphosphatase) on the cell membrane and 
release of  lithium from the cell in exchange 
for sodium. It is considered that because of  
the way   lithium enters into erythrocytes, the 
concentration of  lithium in erythrocytes is a 
better indicatior of  the concentration of  lith-
ium in neurons and therefore the determina-
tion of  lithium in erythrocytes should enter 
the laboratory practices [10]. The results of  
this study showed statistically significant, 
moderate correlation (P = 0.002; r = - 0.54) 
between plasma concentrations of  lithium 
and the lithium concentration in erythro-
cytes, which is consistent with other studies 
of  this type. 
Statistically significant, good to excellent 
correlation, (P <0.0001, r = 0.81), of  the lith-
ium concentration in plasma and the erythro-
cytes, resulting in the work of  authors Camus 
et al., 2003. The concentrations of  lithium 
therein, were determined by atomic absorp-
tion spectrometry and the research was con-
ducted on a larger number of  samples, to be 
precise on 309 blood samples collected from 
165 patients who were treated with lithium. 
Compared to this study, which was conduct-
110
Alcoholism and Psychiatry Research 2017;53:99-114 Grizelj, Crnković, Kostanjšak, Vrkić, Karlović
ed on a quite smaller number of  samples, the 
difference was also in the processing of  sam-
ples before the analysis of  lithium in eryth-
rocytes.
The authors of  this article hemolyzed 
erythrocytes by using 7 ml of  sterile water 
(containing no lithium) and 2 ml of  trichlo-
roacetyl acid which was used for the precipi-
tation of  proteins from a sample and the 
samples were then mixed, centrifuged and 
the supernatant analyzed.  The match of  the 
results of  more studies, which were conduct-
ed by different laboratory methods and dif-
ferent sample processing, confirmed the ex-
pected correlation between the concentration 
of  lithium in plasma and erythrocytes. How-
ever, due to longer sample processing and 
more human labour needed in determining 
the concentration of  lithium in erythrocytes, 
this method probably will never get into the 
routine laboratory practice because it is much 
easier and faster to obtain serum or plasma 
with the centrifuge and thus monitor the con-
centration of  lithium in blood. In this work 
(Camus et al., 2003), authors also investigated 
the contribution of  calculating the concen-
tration of  lithium in erythrocytes and in plas-
ma in differentiating the acute from chronic 
lithium poisoning. The authors came to the 
conclusion that the ratio of  concentrations 
of  lithium in erythrocytes and in plasma is 
higher in chronic poisoning than in acute poi-
soning with lithium, which is expected due to 
the mechanism of  lithium entry into eryth-
rocytes. The authors came to the conclusion 
that this ratio could be used in differentiat-
ing acute from chronic lithium poisoning and 
to decide which therapeutic action to use. In 
this paper, the authors made a comparison 
of  ratio between the concentration of  lithi-
um in erythrocytes and in plasma from dif-
ferent samples and concluded that there are 
significant differences in the ratios between 
the samples of  individual patients (13.25 to 
111.15) which is also in line with recent re-
search [17,4].
In this study, it was concluded that there 
was no statistically significant difference be-
tween the three test methods used for de-
termining the concentration of  lithium (P = 
0.507):  spectrophotometry, flame photom-
etry and ion-selective electrodes. The flame 
photometer, which was used in this study 
(IL943) is no longer used in laboratory prac-
tice because of  an unstable flame system and 
consequently it required frequent calibration 
and also because of  the development of  new 
methods and machines which achieve a better 
level of  automation, but it can be concluded 
that this machine compared with modern 
technology achieves good results. Some pa-
pers state that the concentration of  lithium 
obtained by ion-selective electrode is higher 
than the concentration of  lithium obtained 
by flame photometry and atomic absorp-
tion spectroscopy [1], but this research has 
not produced a statistically significant differ-
ence between the tested methods. In this pa-
per, we made a comparison of  lithium con-
centration in serum, plasma and red blood 
cells with the daily doses of  lithium taken by 
patients.A statistically significant but low cor-
relation was found only when comparing the 
concentration of  lithium in serum obtained 
by ion-selective electrode with therapeu-
tic doses of  lithium (P = 0, 009; r = 0.47). 
Comparing therapeutic doses of  lithium to 
lithium concentrations in serum obtained by 
flame photometry and spectrophotometry, 
the concentration of  lithium in plasma ob-
tained by flame photometry and the calculat-
ed concentration of  lithium in erythrocytes 
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were not significant correlated. The results 
may lead to the conclusion that patients do 
not adhere to prescribed therapy, howev-
er, such a conclusion can not be safely set. 
Comparing the three methods, spectropho-
tometry, electrochemical methods and flame 
photometry, which were used for determin-
ing of  the concentration of  lithium in serum 
samples, it was concluded that there was no 
statistically significant difference between the 
three methods (P = 0.507). Lithium concen-
trations analyzed by electrochemical methods 
could be determined only in serum samples 
due to the interference of  hemoglobin (the 
sample hemolysate) and the interference of  
EDTA (for plasma sample). Using spectro-
photometric methods hemoglobin interferes 
due to the influence of  the hemoglobin color 
in the part of  spectrum in which lithium is 
being measured (600 nm). Flame photometry 
can determine the concentration of  lithium 
in all tested media, but this method has oth-
er shortcomings (lack of  complete automa-
tion, often calibration of  the machine, etc.), 
and therfore it is no longer in the routine 
laboratory practice. Lithium concentrations 
measured using flame photometer are higher 
in erythrocytes than in plasma (P = 0.043). 
There was a modest but statistically signifi-
cant correlation between plasma and eryth-
rocyte concentrations (P = 0.002; r = - 0.54). 
The ratio of  the concentration of  lithium in 
the erythrocytes and in the plasma did not 
indicate that there is regularity in the distribu-
tion of  lithium between plasma and cells. The 
range of  ratios is very wide (13.25 to 111.15) 
and is not in correlation to the therapeutic 
daily dose and therefore is not a better indi-
cator in the control of  the treatment. It was 
concluded that only lithium concentrations in 
serum measured by electrochemical method 
correlate with the daily dose of  lithium (P = 
0.009; r = 0.47), while the concentrations in 
plasma and erythrocytes do not correlate with 
the daily dose and neither does the ratio of  
the concentration of  lithium in plasma and 
erythrocytes. It was confirmed that serum is 
the best sample for measuring the concentra-
tion of  lithium and that the electrochemical 
method of  determining the concentration of  
lithium in serum correlates best with a daily 
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Uspoređivanje koncentracije litija u serumu, plami i eritrocitima
Sažetak - Primjena litija u medicini započela je sredinom 19. stoljeća kada je in vitro prikazana topljivost soli 
mokraćne kiseline u otopini litijeva karbonata što je ukazalo na činjenicu da se litij može koristiti u liječenju 
gihta.  Korištenje litija u psihijatriji započinje 1949. godine kada je dokazan njegov učinak u liječenju mani-
je. Njegov mehanizam djelovanja još nije u potpunosti razjašnjen. Paralelno s korištenjem litija u liječenju 
psihijatrijskih poremećaja razvile su se različite metode za određivanje koncentracije litija u ljudskim uzor-
cima. Prvi cilj studije bio je odrediti razinu litija u uzorcima seruma koristeći elektrokemijske metode, pla-
menu fotometriju, spektrofometriju i usporediti rezultate s rezultatima dobivenim korištenjem ovih metoda. 
Zahvaljujući mogućnosti određivanja litija u raznim medijima, drugi cilj studije bio je procijeniti kliničke vri-
jednosti određivanja koncentracije litija u eritrocitima u odnosu na koncentraciju litija u plazmi. Treći cilj 
bio je istražiti u kojoj se mjeri terapijska doza litija podudara s izmjerenim koncentracijama litija u serumu, 
plazmi i eritrocitima. Zaključeno je da statistički ne postoji značajna razlika između tri laboratorijske metode 
(P.= 0.507). Istražujući povezanost između koncentracije litija u raznim medijima izmjerenim različitim meto-
dama i dnevne terapeutske doze litija, zaključeno je da je statistički značajna poveznica pronađena jedino u 
izmjerenoj koncentraciji litija u serumu pomoću elektrokemijske metode (P 0 0.009; r = 0.47). Statistički je 
značajna umjerena povezanost između koncentracije litija u plazmi i eritrocitima ((P = 0.002; r = - 0.54), i kon-
cetracije litija u eritrocitima su veće od koncentracije litija u plazmi (P = 0,043). Raspon udjela koncentracije 
litija u eritrocitima i plazmi je širok (13.25 do 111.15) i nije povezan s terapeutskom dnevnom dozom i stoga 
nije bolji indikator u kontroli tretmana. 
Ključne riječi: litijske ion selektivne elektrode, plamena fotometrija, spektrofometrija
